https://endpoints.news/contineums-jj-partnered-drug-fails-phase-2-multiple-sclerosis-trial/
Contineum’s J&J-partnered drug fails Phase 2 multiple sclerosis trial
Nov 21, 2025 - Contineum Therapeutics reported a Phase 2 failure with PIPE-307 in multiple sclerosis on Thursday afternoon, but most analysts don’t seem to view the miss as...
fails phasejpartnereddrug
https://endpoints.news/jjs-tau-targeting-antibody-fails-phase-2-alzheimers-study/
J&J’s tau-targeting antibody fails Phase 2 Alzheimer’s study
fails phasejtautargeting